Today: December 2, 2015, 7:57 am

Tomi Sawyer at Merck, to Keynote Present at Protein-Protein Interaction, Oct. 23-24, 2014 in Boston

Tomi Sawyer, Distinguished Scientist & Head of Peptide Drug Discovery & Innovative Technologies at Merck will keynote present at 2nd Protein-Protein Interaction Conference to be held on October 23-24, 2014 in Boston, MA by GTC. 2014-08-12 07:30:31
GTCbio's upcoming 2nd Protein-Protein Interaction Conference to be held on October 23-24, 2014 in Boston, MA will have sessions that cover novel techniques, new algorithms and databases for PPIs, and potential druggable sites for disrupting protein-protein interactions. Attendees will gain an enhanced understanding of the molecular basis of peptide and protein aggregation and insights into the design of inhibitors of peptide and protein aggregation. Some focused topics we will discuss is how inhibiting PPIs can be a promising therapeutic target, PPI interactions within the TNF family, the first small-molecule inhibitors for the CD40–CD40L, and much more including the fundamental aspects of protein-protein interactions. For more information, please visit:

This conference is part of the larger Protein Discovery Summit 2014, which consists of the following co-located conferences:

3rd Protein Kinases & Drug Design
2nd Protein Expression, Characterization & Purification
2nd Antibody & Protein Therapeutics
2nd Protein-Protein Interaction

GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic institutions, government organizations and the financial community.

GTCbio (Global Technology Community), LLC, is a privately-held company founded in 2002.

Press Information
635 W. Foothill Blvd. Monrovia, CA

Kristen Starkey


Published by
Rania hafez

# 224 Words
Related Articles
More From Science
BOC Sciences Introduced Impurities Identification Along [..]
This month, BOC Sciences announced its introduction of impurities identification BOC Sciences manufactures thousands impurities for [..]
Total Solar Eclipse to Hit North America
Residents from about Portland, Oregon, to coastal South Carolina will be able to see the total eclipse on August 21 [..]
Creative Bioarray's New cDNA Sample Enables Deeper [..]
Creative Bioarray, a global leader in the manufacturing of research-use cells including primary cells, tumor cells, stem cells [..]
Creative Diagnostics’ New Policy---Accelerates the Update [..]
Nov 5, NY, USA For gaining global market share, Creative Diagnostics announces the new policy----accelerates the update rate [..]
BOC Sciences Announced Its Optimization of Isotope [..]
BOC Sciences announced its recent optimization of the isotope labeling ( There are in total 12 categories of isotopes provided [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.